| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |